Injectable Therapies in Diabetes

Similar documents
Injectable Therapies in Diabetes

Injectable Therapies in Diabetes

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital

The principles of insulin adjustment guidance

KEEPING SAFE WITH INSULIN THERAPY

How they work and when to take them. Diabetes Medications

Information for Patients

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

Insulin Management. By Susan Henry Diabetes Specialist Nurse

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

BEST 4 Diabetes. Optimisation of insulin module

BEST 4 Diabetes. Optimisation of insulin module

INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period

Diabetes, Type 2 Management

GLP-1 receptor agonists for type 2 diabetes currently available in the U.S.

DIABETES INDICATIONS FOR INSULIN

Drugs used in Diabetes. Dr Andrew Smith

Starting Insulin in General Practice

Oxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease

End of Life Diabetes Care

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

Updated August /08/2020

Peri-operative management of the surgical patient with diabetes GL059

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.

Insulin Safety. Tracey Roe DSN SSOT partnership trust

Dept of Diabetes Main Desk

STEP 3: Add or Substitute with one of

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

Arrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol

PERIOPERATIVE DIABETES GUIDELINE

A patient guide to the use of insulin for diabetes

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

Initiating Injectable Therapy in Type 2 Diabetes

The main symptoms come on over a period of weeks and are:

Correct Site Rotation

What do you need to know before you go home?

When and how to start insulin therapy in type 2 diabetes

Ertugliflozin (Steglatro ) 5 mg daily. May increase to 15 mg daily. Take in the morning +/- food. < 60: Do not initiate; discontinue therapy

Diabetes, Ketone testing in Type 1 Diabetes

THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN

Types of insulin. Your blood glucose levels. Types of insulin

How can we improve outcomes in Type 2 diabetes?

Leicestershire Diabetes Guidelines: Insulin Therapy

Insulin Therapies: An Educational Toolkit

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

Staying safe on an insulin pump

Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

Glucose Control drug treatments

Managing diabetes if you are having a colonoscopy

SCHOOL HEALTH PLAN: DIABETES

INSULIN 101: When, How and What

Clinical Snapshot: Making sense of Autonomic Neuropathy. M S Kamaruddin Consultant Physician South Tees NHS Foundation Trust

Procedure for the prescribing and administration of insulin

the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and

MANAGEMENT OF TYPE 2 DIABETES

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes

Incredible Incretins Abby Frye, PharmD, BCACP

3. Cardiovascular Disease?

Diabetes Newly Diagnosed with NO evidence of DKA

Pump Failure Guidelines

Managing Diabetes when you are having a colonoscopy

Inpatient Diabetes and Hyperglycaemia. Philip Dyer Heart of England NHS Foundation Trust Birmingham

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

GLP-1 RECEPTOR AGONIST SHOULD I TRY IT? VERONICA BRADY, PHD, BC-ADM, CDE PROJECT ECHO JUNE 21, 2018

667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY

Peri-Operative Guidelines for Management of Diabetes Patients

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Insulin Optimisation Workshop. Theingi Aung & Claire Rowell

GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.

The Wheel of Life Exercise. What s Happening? Where to start the beginning. What's in a meter- are they all the same?

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

Diabetes Meds Update Disclaimer and Important Info. Objectives. Page 1. Copyright , Diabetes Education Services

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

Diabetes Medical Management Plan

Chief of Endocrinology East Orange General Hospital

GLP-1 (glucagon-like peptide-1) Agonists (Byetta, Bydureon, Tanzeum, Trulicity, Victoza ) Step Therapy and Quantity Limit Criteria Program Summary

Management of Type 2 Diabetes

INSULIN INITIATION AND INTENSIFICATION WITH A FOCUS ON HYPOGLYCEMIA REDUCTION

STEP THERAPY CRITERIA

Beyond A1C. Non-glycemic Effects of GLP-1 Receptor Agonists. Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows

Insulin Initiation and Intensification. Disclosure. Objectives

Clinical Support Guide Injectable treatments for adults with diabetes

Diabetes Medical Management Plan

Adlyxin. (lixisenatide) New Product Slideshow

Case Study: Competitive exercise

TYPE 1 DIABETES AND EXERCISE. Mark W Savage

Pre admission & surgery Pre-admission Nurses Association SIG Catherine Prochilo Credentialled Diabetes Nurse Educator Sat 23 March 2013

New Medicine Assessment

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service

Transcription:

Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson

Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used profiles and regimes Consider safe practice in injectible therapies

SIGN 154

When do we use injectibles therapies in diabetes? Type 1 diabetes Always require insulin No alternative No insulin production leads to burning of body fats for fuel, and ketone production > DKA Type 2 diabetes - 40-50% may require insulin Insulin resistance after some time- Variable time line - may have poor response to oral agents. Injectibles may be required Insulin or GLP1 antagonist

Which injectibles in T2DM? Patients with low BMI osmotic symptoms, weight loss Consider insulin therapy sooner may be insulin deplete Patients with BMI >30kg/m2 if possible avoid insulin - consider GLP-1 Agonists 40-50% will require insulin therapy eventually Now have combination insulin/glp1 agonist - XULTOPHY

...Insulin in T2DM With concurrent problems, may require insulin urgently for example... Steroid therapy Acute infection Pre or post surgery Gestational diabetes Type 2 diabetes in pregnancy

Normal profile in health In health with no diabetes... Breakfast Lunch Evening Meal Blood sugar Mealtime insulin Background insulin required for basal metabolic requirements

Which insulin to use? Aim to match insulin profile to meet these basic needs and any specific needs of the individual Human vs analogue Rapid action Short action Intermediate action Long action Mixed insulins Insulin mixed with GLP1 Vial form or pens? 200 and 300 iu strengths*****

Commonly used insulin regimes Once daily background insulins To reduces average blood glucose levels eg. Humulin I, Insulatard, Insuman basal, Levemir, Lantus, Abasaglar, Tresiba...often used with oral agents. - less burden for patients or DNs Twice daily insulin regimes Using basal insulins or pre mixed insulins, to target blood glucose profile more specifically e.g. HumulinI, Insuman Comb 50, Novomix 30, Humalog Mix 50...often used to escalate treatment if once daily regime ineffective

Common Insulin regimes cont. Three times daily mixed insulin eg. Humalog Mix 50, Insuman Comb 50 If patient is highly insulin resistant Multiple dose injections basal bolus eg. Insulatard, Lantus or Levemir plus Novorapid or Humalog, Fiasp usually for patients with type 1 diabetes Insulin Pumps Constant infusion of rapid acting insulin T1DM only

Insulin therapy getting it right... Injection technique / timing /compliance Carbohydrates too much/ too little Avoiding and treating hypos appropriately checking BG results not just HbA1c results Lipohypertrophy - 2/3 insulin injectors Hands off / Hands on inspection

...getting it right Self managing where possible morning insulin lunch / tea time results evening insulin supper / b fast results Stable blood sugars lead to HbA1c results and improved outcomes

Getting it wrong... Datix data... Delivery devices Wrong syringes used Withdrawing insulin from pen devices Sharps disposal Insulin prescriptions Communication pathways Patients fasting

Glucagon LikePeptide-1 agonists GLP1s Used only in Type 2 diabetes Increases insulin production when blood glucose levels are high. Reduces insulin production when blood glucose levels are normal Results in No hypos (unless on another agent for example gliclazide or insulin)

GLP1 how do they work? Incretin gut hormone which patients with T2DM often short of GLP1 injections weight loss + improves glycaemic control Slows down gastric emptying reduce appetite Increases feelings of satiety reduce appetite Increases insulin production improves BG control Reduces glucose release from liver improves BG control

GLP1agents commonly in use dulaglutide (Trulicity) Once weekly injections exenatide (Bydureon) once weekly injection liraglutide (Victoza) once daily injection Degludec/liraglutide (Xultophy) once daily insulin/glp1 mixture Useful for patients who need to avoid hypos eg. taxi drivers, HGV drivers Side effect can be nausea initially

Injection techniques Size 4 or 5mm needles now - no need to pinch 90 degree angle Rotate sites / Why? Lypohypertrophy avoidance Encourage patients not to resheath or -reuse needles DSN support initially towards patient self managing - use of Injection prompt sheets Sharps disposal BD safe clip Safety pen needles

DN dependent patients on insulin Observe GGC policy Administration of Insulin by Injection and Blood Glucose Monitoring, District Nursing Syringe/needle - if prescribed insulin is available in vial form- minimise risk of needlestick injuries. If prescribed insulin not available - use a pen device and BD safe clip to remove needle Ask patient to remove needle if possible and place in sharps box Safety pen needles may be available soon

Further Learning 5 Modules available on Learn Pro Contact diabetes team if any concerns or need advice

Any Questions??? Thank you

Thank you